Immunosuppressant Therapy in Pregnant Organ Transplant Recipients

Seminars in Perinatology

Volumn 31, Issue 6, 2007, Pages 363-371

  Fuchs, Karin M ^a   Coustan, Donald R ^b  

^a NewYork Presbyterian Hospital   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

immunosuppressant; pregnancy; teratogen; transplant

Indexed keywords

ANTIMETABOLITE; AZATHIOPRINE; BETAMETHASONE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; DRUG METABOLITE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; MYCOPHENOLIC ACID; TACROLIMUS;

ANEMIA; CLEFT PALATE; DOSE RESPONSE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SAFETY; EAR MALFORMATION; FETUS CIRCULATION; FETUS MALFORMATION; FOOD AND DRUG ADMINISTRATION; GRAFT REJECTION; HUMAN; HYDROPS; INTRAUTERINE GROWTH RETARDATION; MEDICAL EDUCATION; MEDICAL INFORMATION; NONHUMAN; OBSERVATIONAL STUDY; ORGAN TRANSPLANTATION; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PRIORITY JOURNAL; RECIPIENT; REGISTRATION; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR;

FEMALE; FETUS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PRENATAL EXPOSURE DELAYED EFFECTS; SAFETY; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTS;

EID: 36549016131     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2007.09.006     Document Type: Review

References (80)

1. Armenti V.T., Radomski J.S., Moritz M.J., et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl (2004) 103-114
2. Halloran P.F. Immunosuppressive drugs for kidney transplantation. N Engl J Med 351 (2004) 2715-2729
3. Ostensen M., Khamashta M., Lockshin M., et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8 (2006) 209
4. http://www.fda.gov
5. Sibanda N., Briggs J.D., Davison J.M., et al. Pregnancy after organ transplantation: a report from the UK Transplant pregnancy registry. Transplantation 83 (2007) 1301-1307
6. Sgro M.D., Barozzino T., Mirghani H.M., et al. Pregnancy outcome post renal transplantation. Teratology 65 (2002) 5-9
7. Sibley C.P., and Boyd R.D.H. Mechanisms of transfer across the human placenta. In: Fox P.A. (Ed). Fetal and Neonatal Physiology (2004), WB Saunders Company, Philadelphia, PA 111
8. Syme M.R., Paxton J.W., and Keelan J.A. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 43 (2004) 487-514
9. Marin J.J., Briz O., and Serrano M.A. A review on the molecular mechanisms involved in the placental barrier for drugs. Curr Drug Deliv 1 (2004) 275-289
10. Green T.P., O'Dea R.F., and Mirkin B.L. Determinants of drug disposition and effect in the fetus. Annu Rev Pharmacol Toxicol 19 (1979) 285-322
11. Venkataramanan R., Koneru B., Wang C.C., et al. Cyclosporin and its metabolites in mother and baby. Transplantation 46 (1988) 468-469
12. Nandakumaran M., and Eldeen A.S. Transfer of cyclosporin in the perfused human placenta. Dev Pharmacol Ther 15 (1990) 101-105
13. Flechner S.M., Katz A.R., Rogers A.J., et al. The presence of cyclosporine in body tissues and fluids during pregnancy. Am J Kidney Dis 5 (1985) 60-63
14. Bourget P., Fernandez H., and Delouis C. Accumulation of cyclosporine in the conceptus during the first trimester of pregnancy after liver transplantation. Transplantation 51 (1991) 1306-1307
15. Jain A., Venkataramanan R., Fung J.J., et al. Pregnancy after liver transplantation under tacrolimus. Transplantation 64 (1997) 559-565
16. de Boer N.K., Jarbandhan S.V., de Graaf P., et al. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol 101 (2006) 1390-1392
17. Ballard P.L., Granberg P., and Ballard R.A. Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Invest 56 (1975) 1548-1554
18. Beitins I.Z., Bayard F., Ances I.G., et al. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 81 (1972) 936
19. Blanford A.T., and Murphy B.E. In vitro metabolism of prednisone, dexamethasone, and cortisol by the human placenta. Am J Obstet Gynecol 127 (1977) 264-267
20. Anderson G.G., Rotchell Y., and Kaiser D.G. Placental transfer of methylprednisolone following maternal intravenous administration. Am J Obstet Gynecol 140 (1981) 699-701
21. Pinsky L., and DiGeorge A.M. Cleft palate in the mouse: a teratogenic index of glucocorticoid potency. Science 147 (1965) 402
22. Carmichael S.L., and Shaw G.M. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 86 (1999) 242
23. Schatz M., Patterson R., Zeitz S., et al. Corticosteroid therapy for the pregnant asthmatic patient. JAMA 233 (1975) 804
24. Park-Wyllie L., Mazzotta P., Pastuszak A., et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62 (2000) 385
25. Githens J.H., Rosenkrantz J.G., and Tunnock S.M. Teratogenic effects of azathioprine (Imuran). J Pediatr 66 (1965) 959-961
26. Rosenkrantz J.G., Githens J.H., Cox S.M., et al. Azathioprine (Imuran) and pregnancy. Am J Obstet Gynecol 97 (1967) 387-394
27. Williamson R.A., and Karp L.E. Azathioprine teratogenicity: review of the literature and case report. Obstet Gynecol 58 (1981) 247-250
28. Tallent M.B., Simmons R.L., and Najarian J.S. Birth defects in child of male recipient of kidney transplant. JAMA 211 (1970) 1854-1855
29. McKay D.B., Josephson M.A., Armenti V.T., et al. Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant 5 (2005) 1592-1599
30. EBPG Expert Group in Renal Transplantation. European best practice guidelines for renal transplantation. Section IV. 10. Long-term management of the transplant recipient - pregnancy in renal transplant recipients. Nephrol Dial Transplant 17 suppl 4 (2002) 50-55
31. Sifontis N.M., Coscia L.A., Constantinescu S., et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82 (2006) 1698-1702
32. Le Ray C., Coulomb A., Elefant E., et al. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations. Obstet Gynecol 103 (2004) 1091-1094
33. Tjeertes I.F., Bastiaans D.E., van Ganzewinkel C.J., et al. Neonatal anemia and hydrops fetalis after maternal mycophenolate mofetil use. J Perinatol 27 (2007) 62-64
34. Package Insert: CELLCEPT® (mycophenolate mofetil capsules); Roch Laboratories. Revised October 2005
35. Mason R.J., Thomson A.W., Whiting P.H., et al. Cyclosporin-induced fetotoxicity in the rat. Transplantation 39 (1985) 9
36. Tendron-Franzin A. Long-term effects of in utero exposure to cyclosporin A on renal function in the rabbit. J Am Soc Nephrol 15 (2004) 2687-2693
37. Farley D.E., Shelby J., Alexander D., et al. The effect of two new immunosuppressive agents. FK506 and didemnin B, in murine pregnancy Transplantation 52 (1991) 106-110
38. Jankowska I., Oldakowska-Jedynak U., Jabiry-Zieniewicz Z., et al. Absence of teratogenicity of sirolimus used during early pregnancy in a liver transplant recipient. Transplant Proc 36 (2004) 3232-3233
39. Guardia O., Rial Mdel C., and Casadei D. Pregnancy under sirolimus-based immunosuppression. Transplantation 81 (2006) 636
40. Armenti V.T., Moritz M.J., Cardonick E.H., et al. Immunosuppression in pregnancy: choices for infant and maternal health. Drugs 62 (2002) 2361-2375
41. Prakash, Gupta V., Singh S.M., et al. Effect of intrauterine exposure of murine fetus to cyclophosphamide on development of thymus. Immunopharmacol Immunotoxicol 29 (2007) 17-30
42. Kirshon B., Wasserstrum N., Willis R., et al. Teratogenic effects of first-trimester cyclophosphamide therapy. Obstet Gynecol 72 (1988) 462
43. Enns G.M., Roeder E., Chan R.T., et al. Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?. Am J Med Genet 86 (1999) 237
44. Paladini D., Vassallo M., D'Armiento M.R., et al. Prenatal detection of multiple fetal anomalies following inadvertent exposure to cyclophosphamide in the first trimester of pregnancy. Birth Defects Res A Clin Mol Teratol 70 (2004) 99
45. Zemlickis D., Lishner M., Erlich R., et al. Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide. Teratog Carcinog Mutagen 13 (1993) 139
46. Brent R.L. Teratogen update: reproductive risks of leflunomide (Arava). A pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide ho are contemplating fathering a child. Teratology 63 (2001) 106-112
47. Takahashi N., Nishida H., and Hoshi J. Severe B cell depletion in newborns from renal transplant mothers taking immunosuppressive agents. Transplantation 57 (1994) 1617-1621
48. Di Paolo S., Schena A., Morrone L.F., et al. Immunologic evaluation during the first year of life of infants born to cyclosporin-treated female kidney transplant recipients: analysis of lymphocyte subpopulations and immunoglobulin serum levels. Transplantation 69 (2000) 2049-2054
49. Heeg K., Bendigs S., and Wagner H. Cyclosporin A prevents the generation of single positive (Lyt2+L3T4-. Lyt2-L3T4+) mature T cells but not single positive (Lyt2+T3-) immature thymocytes in newborn mice Scand J Immunol 30 (1989) 703-710
50. Schen F.P., Stallone G., Schena A., et al. Pregnancy in renal transplantation: immunologic evaluation of neonates from mothers with transplanted kidney. Transpl Immunol 9 (2002) 161-164
51. Davison J.M., Dellagrammatikas H., and Parkin J.M. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol 92 (1985) 233-239
52. Cimaz R., Meregalli E., Biggioggero M., et al. Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disorders. Lupus 16 (2007) 129-132
53. Willis F.R., Findlay C.A., Gorrie M.J., et al. Children of renal transplant recipient mothers. J Paediatr Child Health 36 (2000) 230-235
54. Stanley C.W., Gottlieb R., Zager R., et al. Developmental well-being in offspring of women receiving cyclosporin post-renal transplant. Transplant Proc 31 (1999) 241-242
55. Stratta P., Canavese C., Giacchino F., et al. Pregnancy in kidney transplantation: satisfactory outcomes and harsh realities. J Nephrol 16 (2003) 792-806
56. Gaughan W.J., Moritz M.J., Radomski J.S., et al. National Transplantation Pregnancy Registry: report on outcomes in cyclosporine-treated female kidney transplant recipients with an interval from transplant to pregnancy of greater than five years. Am J Kidney Dis 28 (1996) 266-269
57. Cowchock F.S., Reece E.A., Balaban D., et al. Repeated fetal losses associated with antiphospholipid antibodies; a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 166 (1992) 1318-1323
58. Reinisch J.M., and Simon N.G. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 202 (1978) 436-438
59. Scott J.R. Fetal growth retardation associated with maternal administration of immunosuppressives. Am J Obstet Gynecol 128 (1977) 668-676
60. Guller S., Kong L., Wozniak R., et al. Reduction of extracellular matrix protein expression in human amnion epithelial cells by glucocorticoids: a potential role in preterm rupture of the fetal membranes. J Clin Endocrinol Metab 80 (1995) 2244
61. Lockwood C.J., Radunovic N., Nastic D., et al. Corticotropin-releasing hormone and related pituitary adrenal axis hormones in fetal and maternal blood during the second half of pregnancy. J Perinat Med 24 (1996) 243-251
62. Speake P.F., Zipitis C.S., Houston A., et al. Taurine transport into fetal cord blood cells: inhibition by cyclosporine A. J Soc Gynecol Invest 11 (2004) 472-477
63. Day C., Hewins P., Sheikh L., et al. Cholestasis in pregnancy associated with ciclosporin therapy in renal transplant recipients. Transpl Int 19 (2006) 1026-1029
64. Kainz A., Harabacz I., Cowlrick I.S., et al. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 70 (2000) 1718
65. Jain A.B., Shapiro R., Scantlebury V.P., et al. Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience. Transplantation 77 (2004) 897-902
66. Muirhead N., Sabharwal A.R., Rieder M.J., et al. The outcome of pregnancy following renal transplantation: the experience of a single center. Transplantation 54 (1992) 429-432
67. Katz F.H., and Duncan B.R. Entry of prednisone into human milk. N Engl J Med 293 (1975) 1154
68. Greenberger P.A., et al. Pharmacokinetics of prednisolone transfer to breast milk. Clin Pharmacol Ther 53 (1993) 324-328
69. Coulam C.B., Moyer T.P., Jiang N.S., et al. Breast-feeding after renal transplantation. Transplant Proc 14 (1982) 605-609
70. Ito S., Blajchman A., Stephenson M., et al. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993 (1993) 1393-1399
71. Grekas D.M., Vasiliou S.S., and Lazarides A.N. Immunosuppressive therapy and breast-feeding after renal transplantation. Nephron 37 (1984) 68
72. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 108 (2001) 776-789
73. Moretti M.E., Verjee Z., Ito S., et al. Breast-feeding during maternal use of azathioprine. Ann Pharmacother 40 (2006) 2269-2272
74. Sau A., Clarke S., Bass J., et al. Azathioprine and breastfeeding: is it safe?. Br J Obstet Gynaecol 114 (2007) 498-501
75. Nyberg G. Breast-feeding during treatment with cyclosporin. Transplantation 65 (1998) 253-255
76. Munoz-Flores-Thiagarajan K.D., Easterling T., Davis C., et al. Breast-feeding by a cyclosporin-treated mother. Obstet Gynecol 97 (2001) 816-818
77. Moretti M.E., Sgro M., Johnson D.W., et al. Cyclosporin excretion into breast milk. Transplantation 75 (2003) 2144-2146
78. Armenti V.T., Radomski J.S., Moritz M.J., et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl (2003) 131-141
79. Gardiner S.J., and Begg E.J. Breastfeeding during tacrolimus therapy. Obstet Gynecol 107 (2006) 453-455
80. French A.E., Soldin S.J., Soldin O.P., et al. Milk transfer and neonatal safety of tacrolimus. Ann Pharmacother 37 (2003) 815-818